Literature DB >> 18039237

Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.

Viviane B Minamoto1, Jonah B Hulst, Michael Lim, William J Peace, Shannon N Bremner, Samuel R Ward, Richard L Lieber.   

Abstract

The effect of physical manipulation on the outcome of neurotoxin (NT) injection was studied in a rat tibialis anterior (TA) model system where dorsiflexion torque could be measured precisely. After determination of initial torque, all rats received a one-time botulinum toxin A (BTX-A) injection (dose 6.0 units/kg in a volume of 100 microL) into the TA midbelly. Four experimental groups were studied: one group was subjected to BTX-A injection alone (BTX-A only, n=8), one was subjected to BTX-A injection followed immediately by 10 isometric contractions (ISO; n=9), and the third was subjected to BTX-A followed immediately by 10 muscle passive stretch/release cycles (PS; n=10). After 1 month, maximum dorsiflexion torque of the injected and contralateral legs was determined followed by quantification of TA fiber area. Post-injection torque was significantly reduced by around 80% in all NT-treated extremities 1 month after injection (p<0.05). While all NT-treated extremities demonstrated a significant torque decrease relative to their pre-injection levels, ISO and PS groups demonstrated significantly lower torques compared with the BTX-A only group which received no physical manipulation (p<0.05) indicating greater efficacy. Perhaps even more surprising was that the ISO and PS groups both demonstrated a significantly smaller contralateral effect compared with the BTX-A only group that received no manipulation (p<0.05) indicating a decreased systemic-effect. Muscle fiber size generally correlated with dorsiflexion torque. These data demonstrate that both neuromuscular activity (seen in the ISO group) and muscle movement (seen in the PS group) increased the efficacy of BTX-A and decreased the systemic side effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039237     DOI: 10.1111/j.1469-8749.2007.00907.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  22 in total

1.  Perm1 enhances mitochondrial biogenesis, oxidative capacity, and fatigue resistance in adult skeletal muscle.

Authors:  Yoshitake Cho; Bethany C Hazen; Paulo G Gandra; Samuel R Ward; Simon Schenk; Aaron P Russell; Anastasia Kralli
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

2.  p300 is not required for metabolic adaptation to endurance exercise training.

Authors:  Samuel A LaBarge; Christopher W Migdal; Elisa H Buckner; Hiroshi Okuno; Ilya Gertsman; Ben Stocks; Bruce A Barshop; Sarah R Nalbandian; Andrew Philp; Carrie E McCurdy; Simon Schenk
Journal:  FASEB J       Date:  2015-12-28       Impact factor: 5.191

3.  The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.

Authors:  Andrea Bonetto; Joseph E Rupert; Rafael Barreto; Teresa A Zimmers
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

4.  Skeletal muscle fibrosis develops in response to desmin deletion.

Authors:  Gretchen A Meyer; Richard L Lieber
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-21       Impact factor: 4.249

5.  Automated image analysis of skeletal muscle fiber cross-sectional area.

Authors:  Jyothi Mula; Jonah D Lee; Fujun Liu; Lin Yang; Charlotte A Peterson
Journal:  J Appl Physiol (1985)       Date:  2012-11-08

6.  Passive mechanical properties and related proteins change with botulinum neurotoxin A injection of normal skeletal muscle.

Authors:  Bryan E Thacker; Akihito Tomiya; Jonah B Hulst; Kentaro P Suzuki; Shannon N Bremner; Randy F Gastwirt; Marion L Greaser; Richard L Lieber; Samuel R Ward
Journal:  J Orthop Res       Date:  2011-08-18       Impact factor: 3.494

7.  Relationships between tissue microstructure and the diffusion tensor in simulated skeletal muscle.

Authors:  David B Berry; Benjamin Regner; Vitaly Galinsky; Samuel R Ward; Lawrence R Frank
Journal:  Magn Reson Med       Date:  2017-10-31       Impact factor: 4.668

8.  Recovery of rat muscle size but not function more than 1 year after a single botulinum toxin injection.

Authors:  Samuel R Ward; Viviane B Minamoto; Kentaro P Suzuki; Jonah B Hulst; Shannon N Bremner; Richard L Lieber
Journal:  Muscle Nerve       Date:  2017-06-15       Impact factor: 3.217

9.  Reduced skeletal muscle satellite cell number alters muscle morphology after chronic stretch but allows limited serial sarcomere addition.

Authors:  Matthew C Kinney; Sudarshan Dayanidhi; Peter B Dykstra; John J McCarthy; Charlotte A Peterson; Richard L Lieber
Journal:  Muscle Nerve       Date:  2016-11-28       Impact factor: 3.217

Review 10.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.